Algeria vs Kuwait: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Algeria
95.0%
in 2025
Kuwait
95.0%
in 2025
Algeria rank
38th
Kuwait rank
38th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Algeria
- Kuwait
How they compare
Algeria currently reports 95.0% against 95.0% in Kuwait, a difference of 0.0%.
Across all 18 years both countries report, Kuwait has been ahead every year.
Algeria ranks 38th and Kuwait ranks 38th of 194 countries.
Kuwait has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Kuwait | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 99.0% | 99.0% | Kuwait |
| 2010s | 32.8% | 97.0% | 64.2% | Kuwait |
| 2020s | 84.8% | 96.5% | 11.7% | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Algeria or Kuwait?
- Algeria, at 95.0% against 95.0% in Kuwait as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Algeria and Kuwait?
- 0.0%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Kuwait?
- 18 years are reported by both, from 2008 to 2025.
- How do Algeria and Kuwait rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Algeria ranks 38th and Kuwait ranks 38th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.